{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,15]],"date-time":"2026-01-15T01:26:52Z","timestamp":1768440412088,"version":"3.49.0"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2017,1,26]],"date-time":"2017-01-26T00:00:00Z","timestamp":1485388800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2017,1,26]],"date-time":"2017-01-26T00:00:00Z","timestamp":1485388800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"name":"Department of Science and Technology Department, Govt of India","award":["SR\/SO\/HS-0161\/2010"],"award-info":[{"award-number":["SR\/SO\/HS-0161\/2010"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Gastrointest Canc"],"published-print":{"date-parts":[[2017,3]]},"DOI":"10.1007\/s12029-017-9919-8","type":"journal-article","created":{"date-parts":[[2017,1,26]],"date-time":"2017-01-26T01:19:21Z","timestamp":1485393561000},"page":"110-116","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":20,"title":["Epigenetic Downregulation of PTEN in Gallbladder Cancer"],"prefix":"10.1007","volume":"48","author":[{"given":"Dinesh Singh","family":"Tekcham","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sanjeev","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Braj Raj","family":"Shrivastav","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pramod Kumar","family":"Tiwari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2017,1,26]]},"reference":[{"key":"9919_CR1","first-page":"2","volume":"7","author":"MA Barbhuiya","year":"2009","unstructured":"Barbhuiya MA, Singh TD, Gupta S, Shrivastav BR, Tiwari PK. Incidence of gall bladder cancer in rural and semi urban population of north-central India; a first insight. Internet J Epidemiol. 2009;7:2.","journal-title":"Internet J Epidemiol"},{"key":"9919_CR2","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1093\/annonc\/mdn533","volume":"20","author":"G Randi","year":"2009","unstructured":"Randi G, Malvezzi M, Levi F, et al. Epidemiology of biliary tract cancers: an update. Ann Oncol. 2009;20:146\u201359.","journal-title":"Ann Oncol"},{"key":"9919_CR3","doi-asserted-by":"publisher","first-page":"125","DOI":"10.4103\/0019-509X.98938","volume":"49","author":"TD Singh","year":"2012","unstructured":"Singh TD, Barbhuiya MA, Poojary S, Shrivastav BR, Tiwari PK. The liver function test enzymes and glucose level are positively correlated in gallbladder cancer: a cancer registry data analysis from north central India. Indian J Cancer. 2012;49:125\u201336.","journal-title":"Indian J Cancer"},{"key":"9919_CR4","doi-asserted-by":"publisher","DOI":"10.1038\/cgt.2015.27","author":"K Tian","year":"2015","unstructured":"Tian K, Di R, Wang L. MicroRNA-23a enhances migration and invasion through PTEN in osteosarcoma. Cancer Gene Ther. 2015; doi:10.1038\/cgt.2015.27.","journal-title":"Cancer Gene Ther"},{"key":"9919_CR5","doi-asserted-by":"publisher","first-page":"7353","DOI":"10.1038\/ncomms8353","volume":"6","author":"L Cai","year":"2015","unstructured":"Cai L, Ye Y, Jiang Q, et al. Epstein-Barr virus-encode microRNA BART1 induces tumour metastasis by regulating PTEN-dependent pathways in nasopharyngeal carcinoma. Nat Commun. 2015;6:7353. doi:10.1038\/ncomms8353.","journal-title":"Nat Commun"},{"key":"9919_CR6","first-page":"4710","volume":"57","author":"PL Dahia","year":"1997","unstructured":"Dahia PL, Marsh DJ, Zheng Z, et al. Somatic deletions and mutations in the Cowden disease gene, PTEN, in sporadic thyroid tumors. Cancer Res. 1997;57:4710\u20133.","journal-title":"Cancer Res"},{"key":"9919_CR7","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1016\/j.tem.2012.11.002","volume":"24","author":"A Ortega-Molina","year":"2013","unstructured":"Ortega-Molina A, Serrano M. PTEN in cancer, metabolism, and aging. Trends Endocrinol Metabolism. 2013;24:184\u20139.","journal-title":"Trends Endocrinol Metabolism"},{"key":"9919_CR8","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1038\/labinvest.3780422","volume":"82","author":"YH Kang","year":"2002","unstructured":"Kang YH, Lee HS, Kim WH. Promoter methylation and silencing of PTEN in gastric carcinoma. Lab Investig. 2002;82:285\u201391.","journal-title":"Lab Investig"},{"key":"9919_CR9","first-page":"271","volume":"9","author":"JK Wiencke","year":"2007","unstructured":"Wiencke JK, Zheng S, Jelluma N, et al. Methylation of the PTEN promoter defines lowgrade gliomas and secondary glioblastoma. Neurooncol. 2007;9:271\u20139.","journal-title":"Neurooncol"},{"key":"9919_CR10","volume-title":"In Rosai and Ackermans surgical pathology","author":"J Rosai","year":"2004","unstructured":"Rosai J. In Rosai and Ackermans surgical pathology. Edinberg: Mosby; 2004."},{"key":"9919_CR11","volume-title":"Molecular cloning: a laboratory manual","author":"J Sambrook","year":"2001","unstructured":"Sambrook J, Russel DW. Molecular cloning: a laboratory manual. 3rd ed. New York: Cold Spring Harbor Laboratory; 2001.","edition":"3"},{"key":"9919_CR12","doi-asserted-by":"publisher","first-page":"9821","DOI":"10.1073\/pnas.93.18.9821","volume":"93","author":"JG Herman","year":"1996","unstructured":"Herman JG, Jeremy RG, Myohanen S, Nelkin BD, Baylin SB. Methylation-specific PCR: a novel PCR assay for methylation status of CpG islands. Proc Natl Acad Sci U S A. 1996;93:9821\u20136.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"9919_CR13","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1007\/s004280100499","volume":"440","author":"K Sato","year":"2002","unstructured":"Sato K, Tamura G, Tsuchiya T, et al. Analysis of genetic and epigenetic alterations of the PTEN gene in gastric cancer. Virchows Arch. 2002;440:160\u20135.","journal-title":"Virchows Arch"},{"key":"9919_CR14","doi-asserted-by":"publisher","first-page":"1505","DOI":"10.1093\/annonc\/mdg407","volume":"14","author":"Y Shinyo","year":"2003","unstructured":"Shinyo Y, Kodama J, Hongo A, Yoshinouchi M, Hiramatsu Y. Heparanase expression is an independent prognostic factor in patients with invasive cervical cancer. Ann Oncol. 2003;14:1505\u201310.","journal-title":"Ann Oncol"},{"key":"9919_CR15","doi-asserted-by":"publisher","first-page":"1735","DOI":"10.1038\/sj.bjc.6604705","volume":"99","author":"IVD Auwera","year":"2008","unstructured":"Auwera IVD, Laere SJV, Bosch SMVD, et al. Aberrant methylation of the adenomatous polyposis coli (APC) gene promoter is associated with the inflammatory breast cancer phenotype. British J Cancer. 2008;99:1735\u201342.","journal-title":"British J Cancer"},{"key":"9919_CR16","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1016\/j.gene.2015.10.004","volume":"576","author":"TD Singh","year":"2016","unstructured":"Singh TD, Gupta S, Shrivastav BR, Tiwari PK. Epigenetic profiling of gallbladder cancer and gallstone diseases: evaluation of tumour associated genes. Gene. 2016;576:743\u201352.","journal-title":"Gene"},{"key":"9919_CR17","doi-asserted-by":"crossref","first-page":"18","DOI":"10.5858\/2007-131-18-ASOCCO","volume":"131","author":"AC Wolff","year":"2007","unstructured":"Wolff AC, Hammond MEH, Schwartz JN, et al. American Society of Clinical Oncology\/College of American Pathologists guideline recommendations for human epidermal growth factor receptor 2 testing in breast cancer. Arch Pathol Lab Med. 2007;131:18\u201343.","journal-title":"Arch Pathol Lab Med"},{"key":"9919_CR18","doi-asserted-by":"publisher","first-page":"1261","DOI":"10.1016\/j.cell.2007.06.009","volume":"129","author":"BD Manning","year":"2007","unstructured":"Manning BD, Cantley LC. AKT\/PKB signaling: navigating downstream. Cell. 2007;129:1261\u201374.","journal-title":"Cell"},{"key":"9919_CR19","doi-asserted-by":"publisher","first-page":"3014","DOI":"10.1158\/0008-5472.CAN-2401-2","volume":"64","author":"A Goel","year":"2004","unstructured":"Goel A, Arnold CN, Niedzwiecki D, et al. Frequent inactivation of PTEN by promoter hypermethylation in microsatellite instability-high sporadic colorectal cancers. Cancer Res. 2004;64:3014\u201321.","journal-title":"Cancer Res"},{"key":"9919_CR20","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1111\/j.1872-034X.2007.00042.x","volume":"37","author":"L Wang","year":"2007","unstructured":"Wang L, Wang WL, Zhang Y, Guo SP, Zhang J, Li QL. Epigenetic and genetic alterations of PTEN in hepatocellular carcinoma. Hepatol Res. 2007;37:389\u201396.","journal-title":"Hepatol Res"},{"key":"9919_CR21","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1002\/gcc.20062","volume":"41","author":"JM Garc\u00eda","year":"2004","unstructured":"Garc\u00eda JM, Silva J, Pe\u00f1a C, et al. Promoter methylation of the PTEN gene is a common molecular change in breast cancer. Genes Chromosomes Cancer. 2004;41:117\u201324.","journal-title":"Genes Chromosomes Cancer"},{"key":"9919_CR22","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1158\/0008-5472.CAN-07-2488","volume":"68","author":"H Yang","year":"2008","unstructured":"Yang H, Kong W, He L, et al. MicroRNA expression profiling in human ovarian cancer: miR-214 induces cell survival and cisplatin resistance by targeting PTEN. Cancer Res. 2008;68:425\u201333.","journal-title":"Cancer Res"},{"key":"9919_CR23","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1053\/j.gastro.2007.05.022","volume":"133","author":"F Meng","year":"2007","unstructured":"Meng F, Henson R, Wehbe-Janek H, Ghoshal K, Jacob ST, Patel T. MicroRNA-21 regulates expression of the PTEN tumor suppressor gene in human hepatocellular cancer. Gastroenterol. 2007;133:647\u201358.","journal-title":"Gastroenterol"},{"key":"9919_CR24","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1038\/ng.370","volume":"41","author":"BS Carver","year":"2009","unstructured":"Carver BS, Tran J, Gopalan A, et al. Aberrant ERG expression cooperates with loss of PTEN to promote cancer progression in the prostate. Nat Genet. 2009;41:619\u201324.","journal-title":"Nat Genet"},{"key":"9919_CR25","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1002\/gcc.10098","volume":"35","author":"T Frisk","year":"2002","unstructured":"Frisk T, Foukakis T, Dwight T, et al. Silencing of the PTEN tumor-suppressor gene in anaplastic thyroid cancer. Genes Chromosomes Cancer. 2002;35:74\u201380.","journal-title":"Genes Chromosomes Cancer"},{"key":"9919_CR26","first-page":"5221","volume":"57","author":"DH Teng","year":"1997","unstructured":"Teng DH, Hu R, Lin H, et al. MMAC1\/PTEN mutations in primary tumor specimens and tumor cell lines. Cancer Res. 1997;57:5221\u20135.","journal-title":"Cancer Res"},{"key":"9919_CR27","first-page":"3657","volume":"57","author":"E Rhei","year":"1997","unstructured":"Rhei E, Kang L, Bogomolniy F, Federici MG, Borgen PI, Boyd J. Mutation analysis of the putative tumor suppressor gene PTEN\/MMAC1 in primary breast carcinomas. Cancer Res. 1997;57:3657\u20139.","journal-title":"Cancer Res"},{"key":"9919_CR28","first-page":"3005","volume":"4","author":"JI Risinger","year":"1998","unstructured":"Risinger JI, Hayes K, Maxwell GL, et al. PTEN mutation in endometrial cancers is associated with favorable clinical and pathologic characteristics. Clin Cancer Res. 1998;4:3005\u201310.","journal-title":"Clin Cancer Res"},{"key":"9919_CR29","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1016\/j.cmet.2014.01.019","volume":"19","author":"S Yue","year":"2014","unstructured":"Yue S, Li J, Lee SY, et al. Cholesteryl ester accumulation induced by PTEN loss and PI3K\/AKT activation underlies human prostate cancer aggressiveness. Cell Metab. 2014;19:393\u2013406.","journal-title":"Cell Metab"},{"key":"9919_CR30","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1016\/j.prp.2011.05.010","volume":"207","author":"DC Liu","year":"2011","unstructured":"Liu DC, Yang ZL. Overexpression of EZH2 and loss of expression of PTEN is associated with invasion, metastasis, and poor progression of gallbladder adenocarcinoma. Pathol Res Pract. 2011;207:472\u20138.","journal-title":"Pathol Res Pract"},{"key":"9919_CR31","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1016\/j.cancergen.2015.09.007","volume":"208","author":"A Ali","year":"2015","unstructured":"Ali A, Mishra PK, Sharma S, Arora A, Saluja SS. Effects of PTEN gene alteration in patients with gallbladder cancer. Cancer Genet. 2015;208:587\u201394.","journal-title":"Cancer Genet"},{"key":"9919_CR32","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13000-015-0381-2","volume":"10","author":"I Roa","year":"2015","unstructured":"Roa I, de Toro G, Fern\u00e1ndez F, Game A, Mu\u00f1oz S, de Aretxabala X, Javle M. Inactivation of tumor suppressor gene pten in early and advanced gallbladder cancer. Diagn Pathol. 2015;10:1.","journal-title":"Diagn Pathol"},{"key":"9919_CR33","doi-asserted-by":"publisher","first-page":"656","DOI":"10.1111\/cbdd.12533","volume":"86","author":"W Lv","year":"2015","unstructured":"Lv W, Wang L, Lu J, Mu J, Liu Y, Dong P. Downregulation of TPTE2P1 inhibits migration and invasion of gallbladder cancer cells. Chemical Biol Drug Design. 2015;86:656\u201362.","journal-title":"Chemical Biol Drug Design"}],"container-title":["Journal of Gastrointestinal Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12029-017-9919-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12029-017-9919-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12029-017-9919-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,8,10]],"date-time":"2021-08-10T12:34:02Z","timestamp":1628598842000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12029-017-9919-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,1,26]]},"references-count":33,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,3]]}},"alternative-id":["9919"],"URL":"https:\/\/doi.org\/10.1007\/s12029-017-9919-8","relation":{},"ISSN":["1941-6628","1941-6636"],"issn-type":[{"value":"1941-6628","type":"print"},{"value":"1941-6636","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,1,26]]},"assertion":[{"value":"26 January 2017","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"After obtaining written consents from patients, surgically removed GBC and GSD tissues were collected from the Department of Pathology, Cancer Hospital and Research Institute, Gwalior, India. The study was approved by the Ethics Committees of the Institutes.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"The study was funded by the Department of Science and Technology, Govt. of India, New Delhi, India (SR\/SO\/HS-0161\/2010).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Funding"}},{"value":"Dr. Dinesh Singh Tekcham was awarded Senior Research Fellowship for Extramural Research (Ref. no. 3\/2\/2\/48\/2011) by the Indian Council of Medical Research, Govt. of India, New Delhi, India. Prof. Pramod Kumar Tiwari has received a research grant from the Department of Science and Technology, Govt. of India, New Delhi, India (SR\/SO\/HS-0161\/2010) to conduct the research. Authors also declare no conflict of interest.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}}]}}